Glucose Monitoring Devices Market Set to Soar to US$ 118.1 Billion by 2033, Riding a Remarkable 16.9% CAGR Surge | Reveals by FMI

According to Future Market Insights' most recent industry report, the global glucose monitoring devices market was valued at roughly US$ 21.3 Billion in 2022 and is expected to rise at a CAGR close to 16.9% over the forecast period, reaching an estimated worth of US$ 118.1 Billion in 2033.

Over the past 20 years, diabetes has escalated to a severe health concern with an unparalleled rate of global growth. It is a significant contributor to death in those aged 20 to 79. The World Health Organization has classified diabetes as a global pandemic due to its rapidly increasing prevalence.

Patients with diabetes require regular monitoring. Costs associated with patient monitoring can be decreased by utilizing technologies for information and communication, artificial intelligence, and smart devices together. Diabetes is mostly brought on by changes in blood glucose levels, and it is important to keep them steady for a set period.

The adoption of continuous glucose monitoring devices, which are emerging as a novel technique for monitoring glucose levels, is growing along with the number of diabetic patients. Every ten minutes, these devices update the real-time glucose level data they provide. The preservation of healthy blood glucose level is the only method for a diabetic to prevent potentially fatal diabetic complications, and glucose monitoring is an essential component of diabetes management.

Get your hands on a visually captivating sample report featuring related graphs and charts. @ 
https://www.futuremarketinsights.com/reports/sample/rep-gb-16747

Non-invasive glucose monitoring has recently become more popular as it lessens the discomfort and suffering experienced by diabetics who must prick their skin more than four times per day to measure their blood glucose levels.

With increasing prevalence of diabetes, as well as advancements in sensor-based technologies for patient monitoring, the market is set to expand at a lucrative pace, over the forecast period.

Key Takeaways from Market Study

-Self-monitoring devices are the leading segment as product, and hold approximately 3%market value share in 2022, owing to their automated and reliable monitoring process.
-Diabetes type II segment is set to lead in terms of indication of glucose monitoring devices with an estimated market value share of around 1%by 2023, owing to the high prevalence of type II diabetes globally.
-By end user, hospitals held a market share of around 7%in 2022, owed to the adoption of continuous monitoring devices in hospitals to reduce the number of fingerstick point of care capillary blood glucose tests, hyperglycemic episodes, and hypoglycemic episodes.
-North America holds a value share of 0%in 2022, owing to the high prevalence of chronic diseases in the region.

 "Rising initiatives to integrate artificial intelligence, as well as digital technologies to blood glucose monitoring devices, as well as growing new product launch activities, are factors propelling the growth of the global glucose monitoring market," says an analyst of Future Market Insights.

Market Competition

Key players' rigorous research led to the development of improved technologies such as flash glucose monitoring and continuous glucose monitoring. Companies also engage in strategic initiatives such as new product launches and mergers and acquisitions.

All consumers with diabetes type 1 are now covered for the Dexcom G6 rtCGM System under the Non-Insured Health Benefits Program, according to an announcement made by Dexcom, Inc. in January 2023.
Abbott disclosed in June 2022 that it is creating a new wearable that combines a sensor to continually monitor. The U.S. FDA has granted the system breakthrough device classification.

Get Ahead with Comprehensive Information - Purchase Today!
https://www.futuremarketinsights.com/checkout/16747

Key Market Players:

-Dexcom, Inc.
-Abbott Laboratories
-Hoffmann-La Roche Ltd (Switzerland)
-Medtronic
-Ascensia Diabetes Care
-Arkray
-Ypsomed AG
-Acon Laboratories
-Nipro
-Nova Biomedical
-Goldsite Diagnostics Inc. (China)
-Lifescan Ip Holdings, LLC
-Prodigy Diabetes Care
-Others

>Key Market Segments Covered in Glucose Monitoring Devices Industry Research

>Product:

-Self-Monitoring Devices
-Continuous Monitoring Devices

>Indication:

-Diabetes Type I
-Diabetes Type II

>End User:

-Hospitals
-Clinics
-Diagnostics Centres
-CHome Care Settings

 Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Read Complete Analysis Here:
https://www.futuremarketinsights.com/reports/glucose-monitoring-devices-market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

This release was published on openPR.